BJL
REGN icon

Brighton Jones LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Brighton Jones LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.74M Buy
+6,131
New +$4.69M 0.1% 134
2025
Q4 		– Sell
-2,906
Closed -$1.63M – 742
2025
Q3 		$1.63M Buy
2,906
+2,335
+409% +$1.32M 0.04% 263
2025
Q2 		$300K Sell
571
-432
-43% -$241K 0.01% 720
2025
Q1 		$636K Buy
1,003
+55
+6% +$37.8K 0.02% 333
2024
Q4 		$675K Buy
948
+686
+262% +$576K 0.02% 329
2024
Q3 		$275K Sell
262
-658
-72% -$732K 0.01% 451
2024
Q2 		$967K Buy
920
+14
+2% +$13.6K 0.03% 232
2024
Q1 		$872K Sell
906
-33
-4% -$31.4K 0.03% 246
2023
Q4 		$825K Sell
939
-2
-0.2% -$1.65K 0.03% 235
2023
Q3 		$774K Buy
941
+54
+6% +$42.4K 0.04% 217
2023
Q2 		$637K Sell
887
-28
-3% -$21.6K 0.03% 258
2023
Q1 		$752K Sell
915
-10
-1% -$7.54K 0.04% 217
2022
Q4 		$667K Sell
925
-9
-1% -$6.64K 0.04% 206
2022
Q3 		$643K Sell
934
-9
-1% -$5.67K 0.04% 207
2022
Q2 		$557K Sell
943
-59
-6% -$38.4K 0.03% 231
2022
Q1 		$700K Buy
1,002
+192
+24% +$121K 0.03% 221
2021
Q4 		$512K Buy
810
+201
+33% +$124K 0.02% 275
2021
Q3 		$369K Buy
609
+53
+10% +$32.9K 0.02% 321
2021
Q2 		$311K Buy
556
+74
+15% +$37.5K 0.02% 347
2021
Q1 		$228K Sell
482
-132
-21% -$64.3K 0.01% 370
2020
Q4 		$297K Buy
614
+203
+49% +$110K 0.02% 292
2020
Q3 		$230K Buy
+411
New +$249K 0.02% 292
2014
Q4 		– Sell
-970
Closed -$350K – 209
2014
Q3 		$350K Hold
970
– – 0.08% 132
2014
Q2 		$274K Hold
970
– – 0.06% 146
2014
Q1 		$291K Hold
970
– – 0.07% 136
2013
Q4 		$267K Sell
970
-53
-5% -$15.2K 0.06% 144
2013
Q3 		$320K Buy
+1,023
New +$269K 0.08% 110

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Brighton Jones LLC's REGN Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 6,131 shares worth $4.74M. The stake represents 0.1% of the portfolio and ranks #134 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in REGN as recently as Q3 2025.

Brighton Jones LLC first reported a position in REGN in Q3 2013 and has held it in 27 quarters since. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Brighton Jones LLC held 6,131 shares of Regeneron Pharmaceuticals worth $4.74M as of Q1 2026.
  • Regeneron Pharmaceuticals was a new Brighton Jones LLC position in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.1% of Brighton Jones LLC's portfolio in Q1 2026, its #134 holding.
  • Brighton Jones LLC first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 27 quarters since.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.